Totally resistant tuberculosis: will antileprosy drugs be helpful?

被引：17

作者：

Brouqui, Philippe

Aubry, Camille

Million, Mathieu

Drancourt, Michel

Raoult, Didier

机构：

[1] IHU MI, Serv Malad Infect, F-13005 Marseille, France

[2] IHU MI, Lab Microbiol Clin, F-13005 Marseille, France

[3] Aix Marseille Univ, URMITE, CNRS 7278, UM63,IRD 198,Inserm 1095, F-13005 Marseille, France

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2013年 / 42卷 / 06期

关键词：

D O I：

10.1016/j.ijantimicag.2013.08.004

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：584 / 585

页数：2

共 5 条

[1] Ivermectin lacks antituberculous activity [J].

Ameen, Sirwan Muhammed ;

Drancourt, Michel .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (08) :1936-1937

[2] The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics [J].

Dubourg, G. ;

Lagier, J. C. ;

Armougom, F. ;

Robert, C. ;

Hamad, I. ;

Brouqui, P. ;

Raoult, D. .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2013, 32 (05) :637-645

[3] Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan [J].

Huang, Tsi-Shu ;

Kunin, Calvin M. ;

Yan, Bo-Shiun ;

Chen, Yao-Shen ;

Lee, Susan Shin-Jung ;

Syu, Wan-Jr .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (03) :633-637

[4]

Kawada Hiroshi, 2008, Kekkaku, V83, P725

[5] Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa [J].

Shean, Karen ;

Streicher, Elizabeth ;

Pieterson, Elize ;

Symons, Greg ;

Smit, Richard van Zyl ;

Theron, Grant ;

Lehloenya, Rannakoe ;

Padanilam, Xavier ;

Wilcox, Paul ;

Victor, Tommie C. ;

van Helden, Paul ;

Groubusch, Martin ;

Warren, Robin ;

Badri, Motasim ;

Dheda, Keertan .

PLOS ONE, 2013, 8 (05)

← 1 →